TABLE 1.

Dosing regimen for each study group from day 1 morning dose to day 5 morning dose^a

Group	Regimen common to both groups	Part of regimen different between groups
1 (n = 7)	Cycloserine (250 mg) p.o. twice daily, PAS (5.28 g) p.o. twice daily	Levofloxacin (750 mg) p.o. once daily, streptomycin (1 g) i.m. once daily
2 (n = 9)	Prothionamide (250 mg) p.o. twice daily, pyrazinamide (1,500 mg) p.o. once daily	Moxifloxacin (400 mg) p.o. once daily, kanamycin (1 g) i.m. once daily

^aPAS, p-aminosalicylic acid; i.m., intramuscular; p.o., per os.